The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

including intense pharmacy competition, threatened new federal government pressures, excessive leverage/debt, plus the potential for recession and a bear market on Wall Street. Technical ...

I have a buy rating on HAL, citing its single-digit earnings multiple, key chart support ... amid heightened competition. Looking ahead, corporate event data provided by Wall Street Horizon ...

“Ultimately, this means greater competition in the market which will ... with the car maker topping the sales charts for the first time 34 years later with a mix of imported and Australian ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Tesla’s (TSLA) car sales in China fell in January as competition from domestic rivals continued to heat up, Arjun Kharpal of CNBC reports. The company sold 63,238 units in January, which was ...

Novartis forecasts further profit and sales growth this year after beating analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto.

CT Group, in collaboration with the district administration and Municipal Corporation, organised the Burlton Park wall painting competition, a vibrant initiative aimed at engaging students in ...

It’s dominated sales charts, crushed the competition, and made itself synonymous with EVs in the Golden State. But 2024 told a slightly different story. While Tesla still leads the pack by a ...

Wall Street isn't buying the optimism. BofA Securities slashed its rating from Neutral to Underperform, trimming its price target to $48 from $61, citing a weak Q1 outlook and rising competition ...